Sabine S. Vs Mitera Hospital (Competition Commission of India)
In a recent ruling, the Competition Commission of India (CCI) addressed the complaint filed by Dr. Sabine S., Managing Director of Sabine Hospital and Research Centre Private Limited, against Mitera Hospital. The complaint centered on alleged misinformation regarding IVF treatment costs, which Dr. Sabine claimed could impact competition in the infertility treatment market. However, the CCI found no prima facie case to warrant an investigation under the Competition Act, 2002.
Case Background
Dr. Sabine S. filed a complaint alleging that Mitera Hospital, through its YouTube channel, published misleading information about the cost of IVF treatments. In particular, the video titled, “Whether IVF treatment can be done for Rs. 50,000 – The reality about treatment cost,” posted on July 25, 2023, was claimed to discourage affordable IVF services. According to Dr. Sabine, this was detrimental to hospitals offering low-cost fertility care, as the video allegedly suggested that lower-cost treatments involved poor-quality drugs or hidden costs.
Claims of Abuse of Dominance
The primary grievance was that Mitera Hospital, with a strong presence on social media, was allegedly abusing its dominant position. The hospital’s YouTube channel, with over 100 videos on pregnancy and infertility treatments, was cited as a significant platform that influenced public opinion. Dr. Sabine contended that this dominance allowed Mitera to control the narrative around IVF costs, creating an unfair competitive advantage.
